🇺🇸 N-Acetyl Cysteine (NAC) in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Constipation — 1 report (10%)
2. Depression — 1 report (10%)
3. Dry Mouth — 1 report (10%)
4. Gingival Swelling — 1 report (10%)
5. Hyperhidrosis — 1 report (10%)
6. Hypoaesthesia — 1 report (10%)
7. Infusion Related Reaction — 1 report (10%)
8. Insomnia — 1 report (10%)
9. Intentional Dose Omission — 1 report (10%)
10. Lung Infection — 1 report (10%)

Source database →

Frequently asked questions

Is N-Acetyl Cysteine (NAC) approved in United States?

N-Acetyl Cysteine (NAC) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for N-Acetyl Cysteine (NAC) in United States?

The Aurum Institute NPC is the originator. The local marketing authorisation holder may differ — check the official source linked above.